Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Bio-Strategy Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (59)
ARTG (24)

Date

2025 (4)
2024 (2)
2023 (7)
2022 (19)
2021 (9)
2020 (10)
2019 (8)
2018 (3)
2017 (15)
2014 (3)
2013 (2)
2012 (1)

Search

Sponsor content

83 result(s) found, displaying 31 to 40

Bio-Strategy Pty Ltd - Tissue typing-related IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Human leukocyte antigen C (HLA-C) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd - Human leukocyte antigen DR (HLA-DR) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Human leukocyte antigen B (HLA-B) typing sera IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Clinical chemistry hormone IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Human neutrophil antigen (HNA) typing IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Clinical chemistry tumour marker IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Clinical chemistry-specific protein IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Multiple HLA/HNA/HPA typing antigen/antibody IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd
Bio-Strategy Pty Ltd- Multiple human leukocyte antigen (HLA) antibodies IVDs Cancelled under Section 41GL(d) of the Act

23 May 2022

Cancellation by sponsor

Requested by Bio-Strategy Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.